Israeli-American biotech Chiasma has raised $70 million in Series E cash, moving on from an aborted collaboration with Roche ($RHHBY) and rolling toward FDA approval ...
Shares of Chiasma Inc. lost more than half their value in premarket trade Monday, after the Food and Drug Administration said the new drug application (NDA) for its treatment of a rare ailment related ...
Bellini, G, and Bianchi, A. 1963. Interchromosomal effects of inversions on crossover rate in maize. Zeit f Vererbungs, 94, 126–132.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results